Zoekresultaten - 65 results
Clinical performance of the novel full-genotyping OncoPredict HPV Quantitative Typing assay using the VALGENT framework.
OncoPredict HPV QT (index test) for the detection of CIN2 + was assessed relative to the GP5 +/6+ Enzyme ImmunoAssay (GP5 +/6+ EIA) (comparator test), using noninferiority criteria. Intra- and interlaboratory ...
Clinical Accuracy of Alinity m HR HPV Assay on Self- versus Clinician-Taken Samples Using the VALHUDES Protocol.
followed by Evalyn Brush (EB; n = 233) or Qvintip (QT; n = 260)] and matched CCS s, were available for the study. Sensitivity to detect cervical intraepithelial neoplasia grade 2 or higher (CIN2) of Alinity ...
HPV testing in Polish population-based cervical cancer screening programme (HIPPO project)-study protocol of a randomised healthcare policy trial.
rates of histologically confirmed high grade intraepithelial lesions or worse (CIN2 +) in each arm. DISCUSSION: his pilot randomised healthcare study nested in the OCCSP in Poland will assess and compare ...
Protocol for a systematic review and meta-analysis of the diagnostic test accuracy of host and HPV DNA methylation in cervical cancer screening and management.
a test to diagnose cervical intraepithelial neoplasia (CIN); we present a protocol to evaluate the accuracy of methylation markers to detect high-grade CIN and cervical cancer. METHODS AND ANALYSIS: We ...
Papilloplex HR-HPV test has non-inferior clinical performance for detection of human papillomavirus infection: assessment using the VALGENT framework.
women diagnosed with histologically confirmed cervical intraepithelial neoplasia two or more (≥ CIN2, N=119) and controls defined as women with two subsequent negative cytology results (N=834). RESULTS: ...
HPV-based Cervical Cancer Screening on Self-samples in the Netherlands: Challenges to Reach Women and Test Performance Questions.
self-sampling (16% in 2020). HPV positivity and detection rate of precancer (CIN3 +) were lower in the self-sampling compared with the clinician-sampling group (adjusted OR s of 0.65 and 0.86, respectively). ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT‐2 framework
GP5 +/6+ PCR enzyme immunoassay (standard comparator assay). Non-inferior accuracy detecting cervical intraepithelial neoplasia of grade 2 or worse (CIN2 +) of the index versus comparator was verified. ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
immunoassay (standard comparator assay). Non-inferior accuracy detecting cervical intraepithelial neoplasia of grade 2 or worse (CIN2 +) of the index versus comparator was verified. Intra- and interlaboratory ...
Clinical and analytical evaluation of the Alinity m HR HPV assay within the VALGENT-3 framework
Alinity m, RealTime, and cobas, and the Linear Array (Roche) was used for more detailed genotyping concordance. In the total study population, the relative sensitivity and specificity for CIN2 + and CIN ...
Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
cervical intraepithelial neoplasia of grade 3 or worse (CIN3 +). METHODS: A literature search was conducted in 3 bibliographic databases. Studies were selected if they included women with ASC- US or LSIL who ...